Navigation Links
Killing brain tumors from within: A 'Trojan horse' approach

A new method for targeting malignant brain tumors through inducing the cancerous cells to "commit suicide" has been developed by a team of researchers headed by a Hebrew University of Jerusalem professor of biochemistry.

Alexander Levitzki, who is the Wolfson Family Professor of Biochemistry, his research associate, Dr. Alexei Shir, and his colleagues from the Ludwig-Maximilians University of Munich, Germany, have pioneered a technique in which a molecule containing long, double-stranded RNA is attached to epidermal growth factor (EGF) and delivered selectively to cells with an abnormally high number of epidermal growth factor receptors (EGFR).

This proliferation of EGFR is typical of certain types of cancer cells, including glioblastoma multiforme (GBM), the most lethal form of brain cancer.

The nucleic acid-EFG molecule acts as a "guided missile," explained Prof. Levitzki, which, when injected into the blood stream, is avidly gobbled up by the multiple EGF receptors on the cancer cells, without harming normal cells. Once embedded in the tumor cells, it destroys them from within ?a true "Trojan horse," said Prof. Levitzki. Normal cells, which possess 20 to100 less receptors for EGF, are spared, since the amount of double-stranded RNA gobbled up is insufficient to induce them to die.

The lethal RNA approach has been applied to mice in which human brain tumors were grown. The tests proved 100% effective in eliminating the tumorous growths.

An article on the work of Prof. Levitzki, along with his associate Dr. Shir and Professors Manfred Orgris and Ernst Wagner of Ludwig-Maximilians University in Munich, was published in a recent article in the journal PLOS Medicine.

Further testing is planned in a clinical setting. In the meantime, a small start-up company, Algen Biopharmaceuticals Ltd., has been established through the Hebrew University's Yissum Technology Transfer Company to promote commercial devel
'"/>

Source:The Hebrew University of Jerusalem


Page: 1 2

Related biology news :

1. Duke Experiments Boost Radiations Cancer-Killing Effects
2. Killing the messenger RNA -- But which one?
3. Controversial drug shown to act on brain protein to cut alcohol use
4. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
5. Mouse brain tumors mimic those in human genetic disorder
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. First atlas of key brain genes could speed research on cancer, neurological diseases
8. NYU study reveals how brains immune system fights viral encephalitis
9. Stem cells from brain transformed to produce insulin at Stanford
10. Birds brains reveal source of songs
11. Loves all in the brain: fMRI study shows strong, lateralized reward, not sex, drive
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Killing brain tumors from within Trojan horse approach

(Date:7/8/2015)... July 8, 2015 The consumer products ... summer,s must have products such as wearables, smart wallets & ... for biometrics based devices continues to rapidly grow.  Biometrics & ... NXTD ), Google Inc. (NASDAQ: GOOG ), Apple ... ), GoPro, Inc. (NASDAQ: GPRO ) and Baidu Inc. ...
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
Breaking Biology News(10 mins):Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... of microbes, as in politics, some groups just can't ... with archaea (ar-KEY-uh), a collection of bacteria-like microorganisms whose ... other living things. , For years, biologists have pigeonholed ... many species of archaea thrive in environments that would ...
... large animal fossils more than 500 million years ago ?a ... as "Darwin’s Dilemma" ?may be due to a huge increase ... Narbonne, an expert in the early evolution of animals and ... research team found the world’s oldest complex life forms between ...
... a clinical trial evaluating new drug combinations for sleeping ... agency Medecins Sans Frontieres (MSF), and its research arm, ... Trials. , African trypanosomiasis, or sleeping sickness affects many ... Africa and is a serious disease for which there ...
Cached Biology News:From hot springs to rice farms, scientists reveal new insights into the secret lives of archaea 2From hot springs to rice farms, scientists reveal new insights into the secret lives of archaea 3From hot springs to rice farms, scientists reveal new insights into the secret lives of archaea 4From hot springs to rice farms, scientists reveal new insights into the secret lives of archaea 5Finding an answer to Darwin's Dilemma 2
(Date:7/28/2015)... , July 28, 2015 Deerfield Management ... Healthcare Innovations Fund, L.P., which will invest in groundbreaking ... in genetic diseases, cancer, and orphan diseases. The venture ... transform how therapeutics are developed and improve the way ... one of the largest healthcare-focused venture funds in the ...
(Date:7/28/2015)... SAN DIEGO , July 28, 2015  Kerastem ... conditional approval from the U.S. FDA Center For Biologics ... Gene Therapies to conduct a clinical trial investigating the ... treatment of female and early male pattern baldness (androgenic ... the STYLE trial, follows initial clinical work in ...
(Date:7/28/2015)... BEACH, Calif. , July 28, 2015 /PRNewswire-USNewswire/ ... announced that it has hit a milestone of ... Signafuse was FDA 510(k) cleared in early 2014 ... use in posterolateral spine fusion procedures.  This is ... products, as less than 6% of new synthetic ...
(Date:7/28/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... granted to German life sciences entrepreneurs with a ... of biotechnology (collectively, the "Optionee"), an option to ... vaccine technology (the "Technology"), including AEZS-120, the most ... ready to enter a Phase 1 clinical trial. ...
Breaking Biology Technology:Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2Revolutionary Bone Graft Exceeds Expectations 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3
... EMERYVILLE, Calif., Sept. 3 NovaBay(R) Pharmaceuticals, Inc. ... company developing non-antibiotic anti-infective compounds for the treatment or prevention ... announced today that Ron Najafi, Ph.D., Chairman and Chief Executive ... Healthcare Conference at 10 a.m., Thursday, Sept. 10, 2009 at ...
... - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX: ONY) ... Officer, will present at the Rodman Renshaw 11th ... York. , Dr. Kirkman will present at 2 p.m. Eastern ... of the presentation will be accessible at http://www.wsw.com/webcast/rrshq15/onty ...
... , , SAN DIEGO, Calif., Sept. ... the Company will present at the following investor conferences: , , ... September 9, 2009 at 10:30 a.m. Eastern Time at the Four Seasons Hotel in ... on Thursday, September 10, 2009 at 3:50 p.m. Eastern Time at the Four Seasons ...
Cached Biology Technology:NovaBay(R) Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference September 10, 2009 in New York City 2NovaBay(R) Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference September 10, 2009 in New York City 3Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 2
Bovine Coronary Artery Endothelial Cells (BCAEC) (>500,000 cells)...
... Receptor antiserum This NPY Y2 antibody ... and is currently being characerized in brain. The ... mouse and appears to work better on mose ... For full characterizarion in dorsal root ganglion and ...
... allows the Thermo-Fast® 96 ... PCR plates to be ... PRISM® 3700 capillary sequencer. ... information on the software ...
... beta Synuclein Synucleins are small, soluble ... in certain tumors. The family includes three ... gamma synuclein. The alpha and beta synuclein ... where they are seen mainly in presynaptic ...
Biology Products: